Skip to main content

Company News

  • April 22, 2026

    Preserving the planet to protect health: our commitments and progress

    Preserving the planet to protect health: our commitments and progress

    Fully aware of today’s climate and environmental challenges, we are taking action to reduce the footprint of our activities, optimize the use of resources, and design increasingly responsible solutions. Since 2019, we have been committed to an ambitious environmental trajectory. Here is an overview of the concrete, measurable, and sustainable actions implemented by our teams around the world.

  • April 01, 2026

    Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

    In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

  • March 23, 2026

    bioMérieux Invests in Plair to Advance Real-Time Environmental Monitoring for Pharmaceutical Industry

    bioMérieux announces an investment of more than one million Swiss Francs in Plair, a scale-up company offering a breakthrough solution for real-time microbial detection and air sampling. 

  • March 09, 2026

    Faster Answers, Clearer Decisions: How Real Life ED Use of Rapid Multiplex PCR Improves the Patient Experience

    Respiratory symptoms send millions of people to emergency departments (EDs) every year. For clinicians, sorting through those symptoms quickly isn’t easy. For patients, that uncertainty can be stressful: long waits, unclear answers, and sometimes unnecessary treatments, including antibiotics that won’t help viral infections.
  • February 16, 2026

    Rising to the Challenge: Harnessing Diagnostics to Combat Infectious Diseases and AMR

    Global health leaders unite to unlock the value of diagnostics in the fight against antimicrobial resistance.